Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Chordoma × Disulfides × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 25 Ovarian Neoplasms 23 Fallopian Tube Neoplasms 21 Carcinoma, Non-Small-Cell Lung 20 Colorectal Neoplasms 14 Glioblastoma 10 Pancreatic Neoplasms 9 Carcinoma, Renal Cell 9 Melanoma 8 Breast Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 7 Carcinoma, Hepatocellular 7 Brenner Tumor 7 Urinary Bladder Neoplasms 6 Mycosis Fungoides 6 Lymphoma, Large B-Cell, Diffuse 6 Brain Neoplasms 6 Prostatic Neoplasms 5 Neoplasm Metastasis 5 Lymphoma, T-Cell, Cutaneous 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Colonic Neoplasms 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Sezary Syndrome 4 Sarcoma 4 Rectal Neoplasms 4 Multiple Myeloma 4 Gliosarcoma 4 Urethral Neoplasms 3

Interventions

Nivolumab 6 Imatinib Mesylate 4 Ipilimumab 3 palbociclib 2 Specimen Handling 2 Radiosurgery 2 Protons 2 Proton Therapy 2 Pemetrexed 2 Magnetic Resonance Spectroscopy 2 Cyclophosphamide 2 Cetuximab 2 tazemetostat 1 spartalizumab 1 relatlimab 1 pembrolizumab 1 camrelizumab 1 avelumab 1 atezolizumab 1 apatinib 1 Zoledronic Acid 1 X-Rays 1 Tiragolumab 1 Thiotepa 1 Surveys and Questionnaires 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Radiation 1 Photochemotherapy 1 Phantoms, Imaging 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03623854 2024-04-16

Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma

Jonsson Comprehensive Cancer Center

Phase 2 Completed

Chordoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡